LRRK2 inhibitors and methods of making and using the same
US10913744B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2016 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | Mar 28, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having the formula I, II, or III: are provided. Compounds of the present disclosure are useful for the treatment of neurodegenerative diseases, such as Parkinson's Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.